发明名称 AMINOTHIAZOLE INHIBITORS OF CYCLIN DEPENDENT KINASES
摘要 Compounds of formula (I) and pharmaceutically acceptable salts thereof. As used in formula (I), and throughout the specification, the symbols have the following meanings: R1 and R2 are independently hydrogen, fluorine or alkyl; R3 is aryl or heteroaryl, R4 has various meanings; R5 is hydrogen or alkyl; m is an integer of 0 to 2; and n is an integer of 1 to 3. The compounds of formula (I) are protein kinase inhibitors and are useful in the treatment an d prevention of proliferative diseases, for example, cancer, inflammation and arthritis. They may also be useful in the treatment of neurodegenerative diseases such as Alzheimer's diseases cardiovascular diseases, viral disease s and fungal diseases.
申请公布号 CA2394538(A1) 申请公布日期 2001.06.21
申请号 CA20002394538 申请日期 2000.12.06
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 WEBSTER, KEVIN R.;POSS, MICHAEL A.;KIMBALL, S. DAVID;MISRA, RAJ N.;RAWLINS, DAVID B.;HAN, WEN-CHING;HUNT, JOHN T.;KIM, KYOUNG S.;CAI, ZHEN-WEI
分类号 C07D277/20;A61K31/426;A61K31/427;A61K31/428;A61K31/433;A61K31/4439;A61K31/454;A61K31/4709;A61K31/4725;A61K31/497;A61K31/506;A61K45/00;A61P1/00;A61P1/04;A61P9/00;A61P9/10;A61P9/14;A61P17/02;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P25/16;A61P25/28;A61P29/00;A61P31/10;A61P31/12;A61P31/18;A61P35/00;A61P35/04;A61P37/06;A61P43/00;C07D263/00;C07D277/00;C07D277/42;C07D277/44;C07D277/54;C07D417/12;C07D417/14;C07D521/00;(IPC1-7):C07D277/54 主分类号 C07D277/20
代理机构 代理人
主权项
地址